↓ Skip to main content
What is this page? Embed badge

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#40 of 3,140)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
15 news outlets
blogs
1 blog
twitter
94 tweeters

Citations

dimensions_citation
215 Dimensions

Readers on

mendeley
228 Mendeley
Summary News Blogs Twitter Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Published in
Journal for Immunotherapy of Cancer, June 2021
DOI 10.1136/jitc-2021-002435
Pubmed ID
34172516
Authors

Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner, Marc S Ernstoff

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 94 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 228 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 228 100%

Demographic breakdown

Readers by professional status Count As %
Other 24 11%
Unspecified 19 8%
Student > Bachelor 18 8%
Researcher 16 7%
Student > Master 13 6%
Other 48 21%
Unknown 90 39%
Readers by discipline Count As %
Medicine and Dentistry 72 32%
Unspecified 19 8%
Biochemistry, Genetics and Molecular Biology 12 5%
Nursing and Health Professions 8 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Other 21 9%
Unknown 91 40%

Attention Score in Context

This research output has an Altmetric Attention Score of 166. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2023.
All research outputs
#223,180
of 23,975,876 outputs
Outputs from Journal for Immunotherapy of Cancer
#40
of 3,140 outputs
Outputs of similar age
#6,348
of 446,002 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 179 outputs
Altmetric has tracked 23,975,876 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,002 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.

This page is provided by Altmetric.